[Adverse reactions of immunomodulatory agents].
Yamanaka
H
H
Kashiwazaki
S
S
D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects*; D050607:Organogold Compounds; D010396:Penicillamine / Q000008:administration & dosage / Q000009:adverse effects*; D062367:ortho-Aminobenzoates / Q000008:administration & dosage / Q000009:adverse effects*
D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D050607:Organogold Compounds; D062367:ortho-Aminobenzoates; C015735:lobenzarit; D010396:Penicillamine; D008727:Methotrexate